In Vitro |
FLT3-IN-18(compound 7d) (0, 0.01, 0.1, 1, 10, 100 nM; 1h) 在 MV4-11 细胞中呈剂量依赖性降低 p-FLT3 Y589/591,p-FLT3 Y842,p-TAT5 Y694,p-ERK1/2 T202/Y204,p-MEK1/2 S217/221,p-AKT S473 的蛋白表达[1]。 FLT3-IN-18 (0, 0.01, 0.1, 1, 10, 100 nM; 24 h) 诱导细胞凋亡和细胞周期停滞在 G1 期[1]。 Cell Proliferation Assay[1] Cell Line: MV4-11, K562, MOLM-13, Kasumi-1, THP-1, U937, MCF-7 cells Concentration: 0-20 µM Incubation Time: 72 h Result: Inhibited cell growth with GI50s of 0.002, 0.380, 0.001, 0.513, 0.713, 0.664, 0.197 µM for MV4-11, K562, MOLM-13, Kasumi-1, THP-1, U937, MCF-7 cells, respectively. Western Blot Analysis[1] Cell Line: MV4-11 cells Concentration: 0, 0.01, 0.1, 1, 10, 100 nM Incubation Time: 1 h Result: Decreased the expression of p-FLT3 Y589/591, p-FLT3 Y842, p-TAT5 Y694, p-ERK1/2 T202/Y204, and p-MEK1/2 S217/221, p-AKT S473 in a dose-dependent manner. Cell Cycle Analysis[1] Cell Line: MV4-11 cells Concentration: 0, 0.01, 0.1, 1, 10, 100 nM Incubation Time: 24 h Result: Induced cell cycle arrest at G1 phase. Apoptosis Analysis[1] Cell Line: MV4-11 cells Concentration: 0, 0.01, 0.1, 1, 10, 100 nM Incubation Time: 24 h Result: Increased cleavage of the apoptotic marker protein PARP-1 (89 kDa fragment) and educed levels of the antiapoptotic protein Mcl-1.
|